<DOC>
	<DOC>NCT01234155</DOC>
	<brief_summary>The purpose of this study is to assess whether 4-months of interval-walking exercise training improves glycemic control in individuals with type 2 diabetes mellitus. The effects of interval-walking training will be compared to continuous-walking exercise in a randomised, controlled trial design. Changes in glycemic control will be examined using oral glucose tolerance tests (OGTT) with stable isotope methodology. In addition, insulin sensitivity and secretion will be examined using glucose clamps combined with glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).</brief_summary>
	<brief_title>Exercise Training and Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>age 18 to 80 normal glucose tolerance, impaired glucose tolerance, or type 2 diabetes (as evidenced by use of oral hypoglycemic medication or 2hour OGTT glucose &gt; 11.1 mmol/l) Insulin treatment or type 1 diabetes BMI &lt;19 or &gt;40 Physically active Undergoing weightloss/gain Pregnancy Contraindication to exercise (ECG/CPX) Significant cardiovascular disease History of renal/hepatic/gastrointestinal/pulmonary disease Clotting or bleeding disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Exercise</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Obesity</keyword>
	<keyword>Insulin Sensitivity</keyword>
	<keyword>Insulin Secretion</keyword>
	<keyword>Beta-cell Function</keyword>
	<keyword>Glycemic Control</keyword>
	<keyword>GIP</keyword>
	<keyword>GLP-1</keyword>
</DOC>